Full Text View
Tabular View
No Study Results Posted
Related Studies
Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma
Expanded access is currently available for this treatment.
( Study has been suspended after the event of an serious adverse event. )
Verified June 2012 by University of California, San Francisco
Study NCT01377532   Information provided by University of California, San Francisco

First Received on June 13, 2011.   Last Updated on June 14, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pheochromocytoma
Paraganglioma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Additional drug interventions recognized in this trial
3-Iodobenzylguanidine
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of California, San Francisco


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services